Blog
RSS FeedPosted by Michael Wonder on 18 Mar 2018
Costco under investigation by Ontario forensic team over drug company payments
16 March 2018 - Rebates not allowed in province in bid to drive down overall price of generics. ...
Posted by Michael Wonder on 15 Mar 2018
Pharmacare and the chaotic world of Canadian drug prices
15 March 2018 - The cost of a life-saving drug to treat cystinosis — a rare disease affecting probably 100 ...
Posted by Michael Wonder on 13 Mar 2018
Canadian families stunned by 3,000% increase in price of life-saving drug
12 March 2018 - Drug for patients with cystinosis being replaced by new form with same active ingredient. ...
Posted by Michael Wonder on 19 Feb 2018
New Patented Medicine Prices Review Board Chairperson announced
17 February 2018 - Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board. ...
Posted by Michael Wonder on 15 Feb 2018
Canadian patient groups call on Federal Health Minister to halt the process examining proposed amendments to the Patented Medicine Regulations pending constructive consultations
15 February 2018 - Patient feedback has not been considered – groups seek meaningful dialogue with Government and drug manufactures ...
Posted by Michael Wonder on 07 Feb 2018
Canadian generic drug prices higher than international levels in recent years
6 February 2018 - The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada. ...
Posted by Michael Wonder on 04 Feb 2018
The real story behind the sudden drop in Canada's drug prices
3 February 2018 - And is Ontario offering a college diploma in 'pseudoscience?' ...
Posted by Michael Wonder on 30 Jan 2018
To avoid open bidding, generic-drug makers cut prices outside Quebec
30 January 2018 - The provinces outside Quebec are expecting to save as much as $3-billion over five years after ...
Posted by Michael Wonder on 21 Jan 2018
At $262.40 per pill, the cancer drug that could save her life isn’t covered in B.C.
19 January 2018 - Karen McLaren of Langley has stage four breast cancer, and has been prescribed a drug that could ...
Posted by Michael Wonder on 16 Jan 2018
How Ottawa's using a fake drug crisis to force through damaging pharmaceutical policy
16 January 2018 - There is no affordability crisis to justify expanding drug price regulation, or a new national government-run pharmacare ...
Posted by Michael Wonder on 05 Dec 2017
Canada's regulator of patented drug prices is rigging data, and risking our health
5 December 2017 - The patent medicine pricing board is making a blatant attempt to bias the data. ...
Posted by Michael Wonder on 04 Dec 2017
Prescription drug costs should be fair – not cheap
4 December 2017 - "Canadians are not getting the value for money on prescription medicine spending or the outcomes they ...
Posted by Michael Wonder on 03 Dec 2017
Ottawa unveils new draft regulations for drug-pricing
2 December 2017 - The Trudeau government is plowing ahead with an overhaul of the country's drug-pricing rules, unveiling draft ...
Posted by Michael Wonder on 31 Oct 2017
Drug firms warn Ottawa against ‘crippling’ price cuts
31 October 2017 - Canada's brand-name pharmaceutical companies are pushing back against a plan to overhaul Canada's drug-pricing regulator, saying ...
Posted by Michael Wonder on 11 Oct 2017
Study finds significant overlap in the drugs covered by Canadian public drug plans
11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...